Ready to dive into #MarketAccess planning for your medical benefit drug? Our primer is your practical guide, leading you through every step, from predicting uptake and tracking policies/pathways to payer contracting and provider engagement. Download the ebook now to discover the five crucial steps your organization should take to establish a firm foundation for your commercialization journey: https://ow.ly/CO5e50Sphlx. #MedicalBenefitTherapy #MedicalBenefitTherapies #CommercializationStrategy #HCPs
MMIT (Managed Markets Insight & Technology)
Information Services
Yardley, Pennsylvania 46,223 followers
About us
For nearly two decades MMIT has been solely focused on solving the “what and why” of drug coverage, and has been a trusted, go-to-market partner to pharma companies, payers and providers. We believe that patients who need lifesaving treatments shouldn’t face delays because accessing drugs can be confusing. As the leading provider of market access data, analytics and insights, our expert teams of clinicians, data specialists and market researchers provide clarity and confidence so that our clients can make better decisions. Divisions of MMIT include AIS Health, creator of the Directory of Health Plans and leading healthcare publications; Zitter Health Insights, a preeminent provider of market access insights and solutions for specialty drugs; RJ Health, the market leader in pricing and coding solutions for infusion drugs covered under the medical benefit; and The Dedham Group, a U.S. market access oncology and specialty therapeutics consultancy offering research, data analytics and strategy formulation services to the life sciences industry.
- Website
-
http://www.mmitnetwork.com
External link for MMIT (Managed Markets Insight & Technology)
- Industry
- Information Services
- Company size
- 201-500 employees
- Headquarters
- Yardley, Pennsylvania
- Type
- Privately Held
- Specialties
- Formulary, Policy & Restriction Transparency, Mobile Formulary Search Application, Launch Commercialization Guidance, and Formulary Management & Publishing
Locations
Employees at MMIT (Managed Markets Insight & Technology)
Updates
-
According to new research from MMIT and The Dedham Group, 73% of pharma companies are using real-world data for purposes beyond #MarketAccess. Learn more about what’s driving this change and the four key points in this breakdown of our survey results. https://ow.ly/GMMv50RZ3t0
-
MMIT's Directory of Health Plans helps organizations understand payer market share with the industry standard of enrollment and affiliation information. Learn more about the Directory of Health Plans: https://ow.ly/58UX50Q9Go2.
-
New in today’s Health Plan Weekly: Experts challenge spector of ACA enrollment fraud, Aetna wins big in Star Ratings redo, FTC raises eyebrows over latest PBM move, and more top stories. https://hubs.ly/Q02Gr5ds0
Health Plan Weekly
mmitnetwork.com
-
Join MMIT for the Strategies for Early Access Planning webinar on July 25th: https://ow.ly/ox8G50SyiLG. Learn how pharmaceutical companies begin pre-launch planning much earlier in the product life cycle as market access challenges grow.
-
-
New in this week's Radar on Drug Benefits: Uptake of Humira biosimilars flattens, why payers haven't picked up Blue Shield of California's PBM unbundling model, provider concerns over white bagging mount, and more top stories. https://hubs.ly/Q02GfSY70 #Pipeline2Patient Norstella
Radar on Drug Benefits
mmitnetwork.com
-
Despite its cost, Wegovy is currently covered at 54% across all channels, according to MMIT’s payer policy and restriction data. https://ow.ly/FpRm50SyXwm MMIT’s Autumn Bowman looks at coverage trends in this high-growth market.
-
-
In this Q&A, MMIT's Andrew Rouff shares insights on payer reactions to drug shortages, the proposed Medicare drug shortage prevention program, and how pharma companies can anticipate utilization. https://ow.ly/5PWN50SrfEw
-
-
What can pharma companies learn about the competitive landscape well before launch? Register to learn how and why manufacturers benefit from early market research. Reserve your seat: https://ow.ly/a5U550SyhK0 This webinar details how and why manufacturers benefit from early market research. Client use cases will show how planning for potential access scenarios leads to greater utilization at launch. Register today!
-
-
What types of real-world data (RWD) do pharma companies use for life cycle management? This infographic shows the percentage of manufacturers relying on RWD: https://ow.ly/tnrp50StOr2. Explore the use cases from Phase I to competitor entry in this infographic.
-